Advances in pluripotent stem cells: history, mechanisms, technologies, and applications

G Liu, BT David, M Trawczynski, RG Fessler - Stem cell reviews and …, 2020 - Springer
Over the past 20 years, and particularly in the last decade, significant developmental
milestones have driven basic, translational, and clinical advances in the field of stem cell …

[HTML][HTML] Bioinks and bioprinting technologies to make heterogeneous and biomimetic tissue constructs

N Ashammakhi, S Ahadian, C Xu, H Montazerian… - Materials Today Bio, 2019 - Elsevier
The native tissues are complex structures consisting of different cell types, extracellular
matrix materials, and biomolecules. Traditional tissue engineering strategies have not been …

3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels

AC Daly, MD Davidson, JA Burdick - Nature communications, 2021 - nature.com
Cellular models are needed to study human development and disease in vitro, and to
screen drugs for toxicity and efficacy. Current approaches are limited in the engineering of …

[HTML][HTML] Organs-on-chips technologies–A guide from disease models to opportunities for drug development

AG Monteduro, S Rizzato, G Caragnano… - Biosensors and …, 2023 - Elsevier
Current in-vitro 2D cultures and animal models present severe limitations in recapitulating
human physiopathology with striking discrepancies in estimating drug efficacy and side …

Electrically conductive nanomaterials for cardiac tissue engineering

K Ashtari, H Nazari, H Ko, P Tebon, M Akhshik… - Advanced Drug Delivery …, 2019 - Elsevier
Patient deaths resulting from cardiovascular diseases are increasing across the globe,
posing the greatest risk to patients in developed countries. Myocardial infarction, as a result …

3D cardiac cell culture: a critical review of current technologies and applications

C Zuppinger - Frontiers in cardiovascular medicine, 2019 - frontiersin.org
Three-dimensional (3D) cell culture is often mentioned in the context of regenerative
medicine, for example, for the replacement of ischemic myocardium with tissue-engineered …

Organ-on-a-chip technology: a novel approach to investigate cardiovascular diseases

V Paloschi, M Sabater-Lleal… - Cardiovascular …, 2021 - academic.oup.com
The development of organs-on-chip (OoC) has revolutionized in vitro cell-culture
experiments by allowing a better mimicry of human physiology and pathophysiology that has …

Multifunctional elastomer cardiac patches for preventing left ventricle remodeling after myocardial infarction in vivo

Y Yao, A Li, S Wang, Y Lu, J Xie, H Zhang, D Zhang… - Biomaterials, 2022 - Elsevier
Myocardial infarction (MI) is still a major cause of mortality and morbidity worldwide.
Elastomer cardiac patches have shown great potential in preventing left ventricle (LV) …

[HTML][HTML] Natural and synthetic antioxidants targeting cardiac oxidative stress and redox signaling in cardiometabolic diseases

M Barteková, A Adameová, A Görbe… - Free Radical Biology …, 2021 - Elsevier
Cardiometabolic diseases (CMDs) are metabolic diseases (eg, obesity, diabetes,
atherosclerosis, rare genetic metabolic diseases, etc.) associated with cardiac pathologies …

[HTML][HTML] Engineering of tissue constructs using coaxial bioprinting

A Kjar, B McFarland, K Mecham, N Harward, Y Huang - Bioactive materials, 2021 - Elsevier
Bioprinting is a rapidly developing technology for the precise design and manufacture of
tissues in various biological systems or organs. Coaxial extrusion bioprinting, an emergent …